Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAMK2B | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | DUSP26 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | NBPF15 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | RALGAPA2 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | CDKN1B | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | PCDHA11 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | FBN3 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | ZNF713 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | ARID1A | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | DEAF1 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |